Center for Diabetes and Metabolism Fachklinik
Andreas Liebl is Medical Director of the Center for Diabetes and Metabolism at the Fachklinik in Bad Heilbrunn, Germany. His research interests include insulin therapy, pharmacoeconomics, insulin pump therapy, intraperitoneal insulin therapy, and continuous glucose monitoring (CGM) and other diabetes technology. Until 2017 Dr Liebl was a long-standing board member of ‘Diabetes Technology – Insulin Pumps and Blood Glucose Sensors’, which is a working group of the German Diabetes Association (DDG). He has also been chairman of the Diabetes Expert Commission FKDB within the DDG. Dr Liebl has been author or co-author of more than 100 national and international publications, and has delivered numerous presentations at scientific meetings all over the world.

Presenter of 3 Presentations

Discussion

Date
Sat, 20.03.2021
Session Time
10:00 - 11:00
Room
Hall A
Lecture Time
10:45 - 11:00

The Relationship between Diabetes, Cardiovascular Disease and Weight

Date
Sat, 20.03.2021
Session Time
10:00 - 11:00
Room
Hall A
Lecture Time
10:05 - 10:11

Introduction

Date
Sat, 20.03.2021
Session Time
10:00 - 11:00
Room
Hall A
Lecture Time
10:00 - 10:05

Moderator of 1 Session

Industry Supported ​Sessions​
Session Type
Industry Supported ​Sessions​
Date
Sat, 20.03.2021
Session Time
10:00 - 11:00
Room
Hall A
Session Description
Managing Cardiovascular Risk in People with Diabetes - Educational Symposium organized by International Medical Press and supported by an educational grant from Novo Nordisk A/S

Session Description

Chaired by Professor Andreas Liebl, this ASCEND educational symposium provides an exclusive platform to exchange expertise on the management of cardiovascular risk in people with diabetes. Faculty will discuss the use of newer glucose-lowering agents with regards to their effects on glycaemic control, weight and cardiovascular outcomes. Practical guidance around selecting the most appropriate agent for different individuals will also be provided. Take this opportunity to share your experiences and have your questions answered by faculty.

The Managing cardiovascular risk in people with diabetes, Virtual Congress, 20/03/2021-20/03/2021 has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 1 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.

Through an agreement between the Union Européenne des Médecins Spécialistes and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 CreditsTM. Information on the process to convert EACCME® credit to AMA credit can be found at www.ama-assn.org/education/earn-credit-participation-international-activities.

Live educational activities, occurring outside of Canada, recognised by the UEMS-EACCME® for ECMEC®s are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.

Session Icon
Live